Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SCHAUMBURG, IL, Feb. 13, 2014 /PRNewswire/ - Catamaran (NASDAQ: CTRX) (TSX: CCT) announces that it will release its fiscal 2013 fourth quarter and year-end financial results on Thursday, February 27, 2014, at 6:00 AM Eastern Time. The Company will hold a conference call at 8:30 AM Eastern Time that same day, Thursday, February 27, 2014, hosted by Mark Thierer, Chairman and CEO, and Jeff Park, Executive Vice President and CFO.
Please dial in 10-15 minutes prior to the call to secure a line.
All interested parties can join the call by dialing 888-726-2418 or 913-312-1513, with access code 9830789. The conference call will be archived for replay until Friday, March 7, 2014, at 11:59 PM Eastern Time. To access the archived conference call, please dial 888-203-1112 or 719-457-0820 and enter the access code 9830789.
This call is being webcast and can be accessed from the Catamaran web site at www.catamaranrx.com. An archived replay of the webcast will be available for 90 days.
Catamaran, the industry's fastest-growing pharmacy benefits manager, helps organizations and the communities they serve take control of prescription drug costs. Managing more than 350 million prescriptions each year on behalf of over 32 million members, our flexible, holistic solutions improve patient care and empower individuals to take charge of their health. Processing one in every five prescription claims in the U.S., Catamaran's skill and scale deliver compelling financial results and sustainable improvement in the overall health of members. Catamaran is headquartered in Schaumburg, Ill., with multiple locations in the U.S. and Canada. For more information, please visit CatamaranRx.com, and for industry news and information follow Catamaran on Twitter, @CatamaranCorp.
©2012 PR Newswire. All Rights Reserved.